{"id":2091,"date":"2025-05-29T11:41:19","date_gmt":"2025-05-29T09:41:19","guid":{"rendered":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/"},"modified":"2025-10-02T15:50:50","modified_gmt":"2025-10-02T13:50:50","slug":"teglutik","status":"publish","type":"page","link":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/","title":{"rendered":"Teglutik"},"content":{"rendered":"<div id=\"block_eb8659c2d7819c27f9af2c48d28f4055\" class=\"hero-block alignfull\" style=\"background-image: url(https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/03\/amyotrophe.jpg)\">\n\t<div class=\"wrap\">\n\t\t\t\t<h1 class=\"entry-title\">Teglutik<sup>\u00ae<\/sup><\/h1>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_2d164db0ec3d7220da2b87b62888a113\" class=\"secondary-menu-block alignfull\" style=\"\">\n<ul class=\"secondary-menu-container\">\n\t\t\t<li class=\"secondary-menu-item\">\n\t\t\t<a class=\"secondary-menu-item__content\" href=\"#teglutik\">Teglutik<sup>\u00ae<\/sup><\/a>\n\t\t<\/li>\n\t\t\t\t<li class=\"secondary-menu-item\">\n\t\t\t<a class=\"secondary-menu-item__content\" href=\"#notice\">Packungsbeilage<\/a>\n\t\t<\/li>\n\t\t\t<\/ul>\n\t<\/div>\n\n\n<div id=\"block_8cc062acaec8c9c14e4df517e96a2f65\" class=\"inner-hero-block product-img-vertical-85 alignfull hero-mbl-column\" style=\"background-image: url(https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/03\/teglutik-bg.svg)\">\n<div class=\"anchor-div\"><\/div>\n\n\t\t\t<div class=\"inner-hero-bg-mbl\" style=\"background-image: url(https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/03\/teglutik-bg.svg); aspect-ratio:393\/200; min-height:200px;\">\n\t<div class=\"img-container\"><img loading=\"lazy\" decoding=\"async\" width=\"481\" height=\"585\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/06\/Teglutik_Packshot_FR.png\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/06\/Teglutik_Packshot_FR.png 481w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/06\/Teglutik_Packshot_FR-247x300.png 247w\" sizes=\"auto, (max-width: 481px) 100vw, 481px\" \/><\/div>\n\t\t\t\t\t<\/div>\n\t<div class=\"wrap\" style=\"flex-direction: row-reverse;\">\n\t\t<div class=\"img-container\" style=\"justify-content: flex-end; max-height: 350px; width: calc(100% - 550px);\"><img loading=\"lazy\" decoding=\"async\" width=\"481\" height=\"585\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/06\/Teglutik_Packshot_FR.png\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/06\/Teglutik_Packshot_FR.png 481w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/06\/Teglutik_Packshot_FR-247x300.png 247w\" sizes=\"auto, (max-width: 481px) 100vw, 481px\" \/><\/div>\n\t\t\t<div class=\"content-container\" style=\"text-align: left;\">\n\t\t\t\t\t\t\t\t\t<div class=\"section-content font-medium\" style=\"max-width: 550px; align-self: flex-start;\"><p><strong>Die amyotrophe Lateralsklerose<\/strong> (ALS) ist eine progressive, neurodegenerative Erkrankung, bei welcher die Nervenzellen, die f\u00fcr die Muskel- und Bewegungskontrolle zust\u00e4ndig sind (Motoneuronen), gesch\u00e4digt werden.<br \/>\n&nbsp;<br \/>\n<strong>Der fortschreitende Muskelschwund und Funktionsverlust f\u00fchrt zu zunehmenden Schwierigkeiten bei der Mobilit\u00e4t, beim Sprechen, Schlucken und Atmen.<\/strong><\/p>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n<style>\n\t.inner-hero-block {\n\t\t@media (min-width: 768px) {\n\t\taspect-ratio: 1440 \/ 350; \n\t\tmin-height: 350px;\n\t\t}\n\t}\n<\/style>\n\n\n<div id=\"hepaxane\" class=\"featured-text-block\">\n\t<div class=\"wrap\">\t\t<div class=\"featured-box\" style=\"background:#00ab5a; box-shadow:10px 10px 0px 0px rgba(0, 171, 90, 0.20);\"><h2 class=\"featured-title\">Teglutik<sup>\u00ae<\/sup>: F\u00fcr alle ALS-Patienten ab der Diagnose und w\u00e4hrend aller Stadien der ALS<\/h2><\/div>\t<\/div>\n<\/div>\n\n\n<div id=\"teglutik\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-half\">\n\t\t\t\t\t\t\t<ul class=\"label_20_regular\">\n<li>In der Schweiz leben derzeit <strong>etwa 600 an ALS Erkrankte<\/strong><sup>1<\/sup>.<\/li>\n<li>J\u00e4hrlich erkranken ca. <strong>200 Menschen neu an ALS<\/strong><sup>1<\/sup>.<\/li>\n<li>Die individuellen Krankheitsverl\u00e4ufe sind sehr unterschiedlich. Etwa 10-20% der Patienten leben l\u00e4nger als 10 Jahre<sup>2<\/sup>.<\/li>\n<\/ul>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-half\">\n\t\t\t<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-large wp-image-2344\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/07\/image005_teglutik-1024x114.png\" alt=\"\" width=\"768\" height=\"86\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/07\/image005_teglutik-1024x114.png 1024w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/07\/image005_teglutik-300x34.png 300w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/07\/image005_teglutik-768x86.png 768w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/07\/image005_teglutik-1536x172.png 1536w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/07\/image005_teglutik.png 1656w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/><\/p>\n\t\t<\/div>\n\t\t\t\t\t<div class=\"full-width-bottom-text\">\n\t\t\t\t<div class=\"label_20_regular pt70 border-top-blue\">\n<p>Seit 2018 bietet EFFIK <strong>Teglutik<sup>\u00ae<\/sup><\/strong> an, das erste <strong>Riluzol in Suspensionsform, das f\u00fcr ALS-Patienten in ALLEN Stadien<\/strong> der Krankheit entwickelt wurde: <strong>ab der Diagnose, w\u00e4hrend der Dysphagie, bis hin zur Administration mittels einer Gastrostomie-Sonde (PEG)<\/strong>.<\/p>\n<p><strong>Riluzol<\/strong> erh\u00f6ht die \u00dcberlebensrate von Patienten mit ALS und dies unabh\u00e4ngig von der prim\u00e4ren Verlaufsform der Krankheit (bulb\u00e4re oder periphere Verlaufsform)<sup>4<\/sup>.<\/p>\n<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_9e2e50d488b51da7f6d5b628d33e4bb8\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<div class=\"h_28_700\">Ihre Patienten profitieren von Teglutik<sup>\u00ae<\/sup> von Beginn an und in allen Stadien<\/div>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"right-content-nocolumns pt0\"><img decoding=\"async\" class=\"alignleft size-large wp-image-1713\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Teglutik24_web_graph_1_DE-1024x375.png\" alt=\"\" width=\"100%\" height=\"auto\" \/><\/div>\n<div class=\"body_14_regular pt24\">Schema modizifiert nach Pena MJ et al. 2012<sup>5<\/sup><\/div>\n\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_b21486baf32b2cf2e90bb989e58024c1\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<div class=\"heading_32_semibold\">Teglutik<sup>\u00ae<\/sup>&#8230;<\/div>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"teglutik-table-title\">Ab der ALS-Diagnose<\/div>\n<div class=\"teglutik-table\">\n<div class=\"teglutik-table-row\">\u2026erm\u00f6glicht die richtige Dosierung entsprechend der Vertr\u00e4glichkeit des Patienten.<\/div>\n<div class=\"teglutik-table-row\">\u2026bietet die passende Galenik w\u00e4hrend der gesamten Behandlung.<\/div>\n<\/div>\n<div class=\"teglutik-table-title\">Zu Beginn der Dysphagie<\/div>\n<div class=\"teglutik-table\">\n<div class=\"teglutik-table-row\">\u2026vermeidet das M\u00f6sern von Riluzol-Tabletten.<\/div>\n<div class=\"teglutik-table-row\">\u2026vermeidet Aspirationen.<\/div>\n<div class=\"teglutik-table-row\">\u2026verhindert therapeutische Unterbrechungen.<\/div>\n<div class=\"teglutik-table-row\">\u2026er\u00fcbrigt einen Wechsel der Galenik.<\/div>\n<div class=\"teglutik-table-row\">\u2026garantiert die richtige Dosierung.<\/div>\n<div class=\"teglutik-table-row\">\u2026verhindert das Gef\u00fchl der Niederlage gegen die Krankheit.<\/div>\n<\/div>\n<div class=\"teglutik-table-title\">Ab Einsatz der PEG-Sonde<\/div>\n<div class=\"teglutik-table\">\n<div class=\"teglutik-table-row\">\u2026vermeidet das M\u00f6sern von Riluzol- Tabletten.<\/div>\n<div class=\"teglutik-table-row\">\u2026garantiert die richtige Dosierung.<\/div>\n<div class=\"teglutik-table-row\">\u2026erleichtert die Administration.<\/div>\n<div class=\"teglutik-table-row\">\u2026verhindert die Verstopfung der Sonde.<\/div>\n<div class=\"teglutik-table-row\">\u2026hat die gleiche Bioverf\u00fcgbarkeit wie die oral verabreichte Suspension<sup>6<\/sup>.<\/div>\n<\/div>\n\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_20793932cae244a52cf4950e1a885906\" class=\"teglutik-feature-block\" style=\"\">\n\t<div class=\"wrap\">\n\t\t<div class=\"feature-columns-container\"><div class=\"item\"><div class=\"left-col\">Dosierung<\/div><div class=\"center-col\"><p><strong>2 \u00d7 T\u00c4GLICH 10 ml TEGLUTIK<sup>\u00ae<\/sup><\/strong><\/p>\n<p>10 ml enthalten 50 mg Riluzol<\/p>\n<\/div><\/div><div class=\"item\"><div class=\"left-col\">Einfache und praktische<br\/>Anwendung<\/div><div class=\"center-col\"><p>Direkt gebrauchsfertig \u2013 kein M\u00f6rsern und Suspendieren<\/p>\n<p>Genau dosierbar mit beigelegter 10 ml-Dosierspritze<\/p>\n<p>Einfache Entnahme durch integrierten Adapter<\/p>\n<\/div><\/div><div class=\"item\"><div class=\"left-col\">Produktdetails<\/div><div class=\"center-col\"><p><strong>Konzentration<\/strong>: 50mg\/10ml<\/p>\n<p><strong>Darreichungsform<\/strong>: orale Suspension<\/p>\n<p><strong>Packungsgr\u00f6sse<\/strong>: 300 ml<\/p>\n<p><strong>Haltbarkeit<\/strong>: 3 Jahre, nach dem \u00d6ffnen 15 Tage<\/p>\n<p><strong>Lagerung<\/strong>: Nicht \u00fcber 30 \u00b0C lagern.<\/p>\n<\/div><\/div><\/div><div class=\"right-col\"><img loading=\"lazy\" decoding=\"async\" width=\"455\" height=\"485\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/05\/teglutik-1.png\" class=\"right-img\" alt=\"\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/05\/teglutik-1.png 455w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/05\/teglutik-1-281x300.png 281w\" sizes=\"auto, (max-width: 455px) 100vw, 455px\" \/><\/div>\t<\/div>\n<\/div>\n\n\n<div id=\"block_31bc8a37ad34a3ed6b6b9f42cf3de482\" class=\"effilevo-block\" style=\"\">\n\t<div class=\"wrap\">\n\t\t<div id=\"product\" class=\"product-box-container\"><div class=\"product-info\"><\/div><\/div><div id=\"notice\" class=\"leaflet-container\"><div class=\"leaflet-item\"><div class=\"leaflet-title\">Abgek\u00fcrzte Fachinformation Teglutik<sup>\u00ae<\/sup> (Trinkbare Suspension, die 50 mg Riluzol f\u00fcr 10 ml enth\u00e4lt). \r\n<\/div><a class=\"blue-button\" href=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/RCP_Teglutik_DE.pdf\">Hier herunterladen<\/a><\/div><div class=\"disclaimer\"><p><b>AUSF\u00dcHRLICHE ANGABEN SIND IN DER FACHINFORMATION AUF DER SWISSMEDIC PLATTFORM PUBLIZIERT <\/b><u><b><i><a href=\"https:\/\/www.swissmedicinfo.ch\" target=\"_blank\" rel=\"noopener\">WWW.SWISSMEDICINFO.CH<\/a><\/i><\/b><\/u><b>.\u00a0<\/b><\/p>\n<p><b>Zulassungsinhaberin: EFFIK SA, 1260 NYON. <\/b><\/p>\n<\/div><\/div><div class=\"references\"><p>1. Schweikert, K. Scl\u00e9rose lat\u00e9rale amyotrophique. Swiss Medical Forum 2015, 15(46), 1068-1073.<br \/>\n2. Chi\u00f2 A, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-323. doi:10.3109\/17482960802566824.<br \/>\n3. Onesti E. et al. Dysphagia in Amyotrophic Lateral Sclerosis: Impact on patient behavior, diet adaptation, and riluzole management. Front. Neurol. 8:94. doi: 10.3389\/fneur.2017.00094.<br \/>\n4. Hinchcliffe M, Smith A. Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degener Neurol Neuromuscul Dis. 2017 May 29;7:61-70.<br \/>\n5. Pena MJ et al. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2012 Oct;13(6):550-4.<br \/>\n6. Brooks BR et al. Riluzole Oral Suspension: Bioavailability Following Percutaneous Gastrostomy Tube-modeled Administration Versus Direct Oral Administration. Clin Ther. 2019 Dec;41(12):2490-2499.<\/p>\n<\/div>\t<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1227,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":{"2":"type-page","4":"hentry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Teglutik - EFFIK HCP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teglutik - EFFIK HCP\" \/>\n<meta property=\"og:url\" content=\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/\" \/>\n<meta property=\"og:site_name\" content=\"EFFIK HCP\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-02T13:50:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/\",\"url\":\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/\",\"name\":\"Teglutik - EFFIK HCP\",\"isPartOf\":{\"@id\":\"https:\/\/effik.ch\/hcp\/#website\"},\"datePublished\":\"2025-05-29T09:41:19+00:00\",\"dateModified\":\"2025-10-02T13:50:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/effik.ch\/hcp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teglutik\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/effik.ch\/hcp\/#website\",\"url\":\"https:\/\/effik.ch\/hcp\/\",\"name\":\"EFFIK HCP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/effik.ch\/hcp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teglutik - EFFIK HCP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/","og_locale":"de_DE","og_type":"article","og_title":"Teglutik - EFFIK HCP","og_url":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/","og_site_name":"EFFIK HCP","article_modified_time":"2025-10-02T13:50:50+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/","url":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/","name":"Teglutik - EFFIK HCP","isPartOf":{"@id":"https:\/\/effik.ch\/hcp\/#website"},"datePublished":"2025-05-29T09:41:19+00:00","dateModified":"2025-10-02T13:50:50+00:00","breadcrumb":{"@id":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/effik.ch\/hcp\/neurologie\/amyotrophe-lateralsklerose\/teglutik\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/effik.ch\/hcp\/"},{"@type":"ListItem","position":2,"name":"Teglutik"}]},{"@type":"WebSite","@id":"https:\/\/effik.ch\/hcp\/#website","url":"https:\/\/effik.ch\/hcp\/","name":"EFFIK HCP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/effik.ch\/hcp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/2091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/comments?post=2091"}],"version-history":[{"count":8,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/2091\/revisions"}],"predecessor-version":[{"id":2473,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/2091\/revisions\/2473"}],"up":[{"embeddable":true,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/1227"}],"wp:attachment":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/media?parent=2091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}